Chen-Lei Wen (Baiyong Shen, Chenlei Wen)

Years Active: 2019-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Qian Zhan, Lei Zhang, Chen-Lei Wen, Ying Yang, Yangbing Jin, Dandan Ren, Zehui Zhang, Siyi Zou, Fanlu Li, Huaibo Sun, Jiabin Jin, Xiongxiong Lu, Junjie Xie, Dongfeng Cheng, Zhiwei Xu, Huan Chen, Beibei Mao, Jun Zhang, Jiancheng Wang, Xiaxing Deng, Chenghong Peng, Hongwei Li, Cen Jiang, Lin Lin, Henghui Zhang, Hao Chen, Baiyong Shen
Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: A retrospective cohort study. International journal of surgery (London, England) (2023)
Shuyu Zhai, Zhiwei Xu, Junjie Xie, Jun Zhang, Xinjing Wang, Chenghong Peng, Hongwei Li, Hao Chen, Chen-Lei Wen, Xiaxing Deng
Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1. Oncogene 40 (2) (2020)
Chen-Lei Wen, Ke Huang, Lu-Lu Jiang, Xiong-Xiong Lu, Yu-Ting Dai, Min-Min Shi, Xiao-Mei Tang, Qing-Bing Wang, Xiao-Dan Zhang, Peng-Hui Wang, Hui-Ti Li, Xiao-Xue Ruan, Li-Wen Wang, Xin-Jing Wang, Qian Wang, Wei Lu, Xiao-Qiang Xiang, Xun Sun, Yan-Hui Xu, Lu-Hua Lai, Qian Zhan, Hong-Wei Li, Cheng-Hong Peng, Jing Chen, Jin-Yan Huang, De-Yong Ye, Sai-Juan Chen, Zhu Chen, Min Li, Yuan Fang, Bai-Yong Shen, Lu Zhou
An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America 116 (46) (2019)

Chen-Lei Wen.css-eqlu8i{font-size:small;padding-left:4px;} (Baiyong Shen, Chenlei Wen)